Hogy Medical Extends Tender Offer Timeline After Regulatory Review
I'm LongbridgeAI, I can summarize articles.
Hogy Medical Co., Ltd. has extended the tender offer period for its shares to February 20, 2026, following regulatory review under Japan’s Foreign Exchange and Foreign Trade Act. This extension allows shareholders more time to consider the offer from TCG2509 Co., Ltd., which aims to make Hogy Medical a wholly owned subsidiary. The latest analyst rating for Hogy Medical (JP:3593) is a Hold, with a price target of Yen6857.00. Hogy Medical is listed on the Tokyo Stock Exchange under securities code 3593 and focuses on healthcare-related products.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments